Бронхіальна астма - Міністерство охорони здоров'я України

73. Brand PL, Postma DS, Kerstjens HA, Koeter GH. Relationship of airway hyperresponsiveness torespiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The DutchCNSLD Study Group. Am Rev Respir Dis 1991;143(5 Pt 1):916-21.74. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications fortreatment. Thorax 2002;57(2):178-82.75. James AL, Finucane KE, Ryan G, Musk AW. Bronchial responsiveness, lung mechanics, gas transfer,and corticosteroid response in patients with chronic airflow obstruction. Thorax 1988;43(11):916-22.76. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial responsiveness to methacholine inchronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984;39(12):912-8.77. Goldstein MF, Veza BA, Dunsky EH, Dvorin DJ, Belecanech GA, Haralabatos IC. Comparisons of peakdiurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalationchallenges in the evaluation of suspected asthma. Chest 2001;119(4):1001-10.78. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitricoxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172(4):453-9. .79. Smith AD, Cowan JO, Filsell S, McLachlan C, Monti-Sheehan G, Jackson P, et al. Diagnosing asthma:comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit CareMed. 2004;169(4):473-8. (34 ref).80. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinicalapplication and interpretation. Thorax 2006;61(9):817-27.81. Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, et al. Sputum eosinophiliaand short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlledtrial. Lancet 2000;356(9240):1480-5.82. Chatkin JM, Ansarin K, Silkoff PE, McClean P, Gutierrez C, Zamel N, et al. Exhaled nitric oxide as anoninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999;159(6):1810-3.83. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsiveasthma. Lancet 1999;353(9171):2213-4.84. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbationsand sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360(9347):1715-21.85. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurementsto guide treatment in chronic asthma. N Engl J Med 2005;352(21):2163-73.86. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, et al. Determining asthmatreatment by monitoring sputum cell counts: Effect on exacerbations. Eur Respir J. 2006;27(3):483-94.87. Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, et al. Alveolar nitric oxide in adultswith asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 2005;25(6):986-91.88. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusion andrecommendations of a working party of the European Respiratory Society. Eur Respir J Suppl. 1997;24:2S-8S.89. D‘Alonzo GE, Steinijans VW, Keller A. Measurements of morning and evening airflow grosslyunderestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma. Am J Respir CritCare Med 1995;152(3):1097-9.90. Chowienczyk PJ, Parkin DH, Lawson CP, Cochrane GM. Do asthmatic patients correctly record homespirometry measurements? BMJ 1994;309(6969):1618.91. Higgins BG, Britton JR, Chinn S, Jones TD, Jenkinson D, Burney PG, et al. The distribution of peakflow variability in a population sample. Am Rev Respir Dis 1989;140(5):1368-72.92. Higgins BG, Britton JR, Chinn S, Cooper S, Burney PG, Tattersfield AE. Comparison of bronchialreactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis1992;145(3):588-93.93. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peakexpiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis1991;143(2):323-30.94. Lebowitz MD, Krzyzanowski M, Quackenboss JJ, O‘Rourke MK. Diurnal variation of PEF and its use inepidemiological studies. Eur Respir J Suppl. 1997(24):49s-56s.231